Priority Date: 14.02.08 (EP 20080447011)

IMMUNOGENIC CONTROL OF TUMOURS AND TUMOUR CELLS

  • Application ID: EP09710780
  • Status: The patent has been granted

Applicants

Research organisation logo small
Research Organisation
Research organisation logo small
Research Organisation

Attorneys

no operation time available
Headquarter in Winksele and 2 offices
active in Legal Services and IP Consulting
no operation time available
849.85
Headquarter in Heverlee and 2 offices
active in Legal Services, IP Consulting, IP Portfolio Processing, and IP-related Communication Service
no operation time available
Headquarter in Winksele and 2 offices
active in Legal Services and IP Consulting
Employment test 11 - 50 employees
Company dna de clercq and partners
operating since 1998
Headquarter in Sint-Martens-Latem and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC class A61, C07, and C12. De Clercq & Partners cvba is specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 133 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 14.02.2008 - Priority Date (EP 20080447011)
  • 20.08.2009 - Publication A2 (WO2009101205)
  • 10.11.2010 - Publication A2 (EP2247306)
  • 18.04.2018 - Publication B1 (EP2247306)